Western Wealth Management’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $428K | Buy |
3,863
+23
| +0.6% | +$2.55K | 0.03% | 454 |
|
2025
Q1 | $430K | Buy |
3,840
+30
| +0.8% | +$3.36K | 0.03% | 432 |
|
2024
Q4 | $352K | Sell |
3,810
-4,662
| -55% | -$431K | 0.02% | 472 |
|
2024
Q3 | $710K | Buy |
8,472
+4,762
| +128% | +$399K | 0.04% | 365 |
|
2024
Q2 | $255K | Sell |
3,710
-1,630
| -31% | -$112K | 0.02% | 545 |
|
2024
Q1 | $391K | Sell |
5,340
-3,283
| -38% | -$240K | 0.03% | 428 |
|
2023
Q4 | $699K | Buy |
8,623
+576
| +7% | +$46.7K | 0.05% | 340 |
|
2023
Q3 | $603K | Buy |
8,047
+5,361
| +200% | +$402K | 0.05% | 343 |
|
2023
Q2 | $207K | Buy |
2,686
+7
| +0.3% | +$540 | 0.02% | 605 |
|
2023
Q1 | $222K | Buy |
2,679
+7
| +0.3% | +$581 | 0.02% | 585 |
|
2022
Q4 | $229K | Sell |
2,672
-6,271
| -70% | -$539K | 0.02% | 540 |
|
2022
Q3 | $554K | Sell |
8,943
-673
| -7% | -$41.7K | 0.03% | 447 |
|
2022
Q2 | $596K | Buy |
9,616
+1,039
| +12% | +$64.4K | 0.03% | 425 |
|
2022
Q1 | $510K | Buy |
8,577
+2,725
| +47% | +$162K | 0.02% | 526 |
|
2021
Q4 | $426K | Buy |
+5,852
| New | +$426K | 0.04% | 362 |
|
2021
Q2 | $323K | Buy |
+4,693
| New | +$323K | 0.03% | 474 |
|
2020
Q4 | – | Sell |
-3,692
| Closed | -$234K | – | 474 |
|
2020
Q3 | $234K | Buy |
3,692
+8
| +0.2% | +$507 | 0.04% | 380 |
|
2020
Q2 | $283K | Buy |
3,684
+528
| +17% | +$40.6K | 0.05% | 328 |
|
2020
Q1 | $236K | Buy |
+3,156
| New | +$236K | 0.05% | 313 |
|
2019
Q1 | – | Sell |
-4,220
| Closed | -$267K | – | 382 |
|
2018
Q4 | $267K | Buy |
+4,220
| New | +$267K | 0.07% | 270 |
|